These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiovascular disease epidemiology in Asia: an overview. Ohira T; Iso H Circ J; 2013; 77(7):1646-52. PubMed ID: 23803294 [TBL] [Abstract][Full Text] [Related]
4. Childhood Obesity and Cardiovascular Disease Risk: Working Toward Solutions. McPhee PG; Singh S; Morrison KM Can J Cardiol; 2020 Sep; 36(9):1352-1361. PubMed ID: 32622878 [TBL] [Abstract][Full Text] [Related]
5. Management of inherited atherogenic dyslipidemias in children. Guardamagna O; Cagliero P; Abello F Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671 [TBL] [Abstract][Full Text] [Related]
6. Recognition and management of dyslipidemia in children and adolescents. Kwiterovich PO J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. Armenian SH; Xu L; Ky B; Sun C; Farol LT; Pal SK; Douglas PS; Bhatia S; Chao C J Clin Oncol; 2016 Apr; 34(10):1122-30. PubMed ID: 26834065 [TBL] [Abstract][Full Text] [Related]
8. Are pediatricians responsible for prevention of adult cardiovascular disease? McGill HC; McMahan CA; Gidding SS Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):10-1. PubMed ID: 18957957 [TBL] [Abstract][Full Text] [Related]
9. Prevention of cardiovascular complications of diabetes mellitus by aspirin. Nobles-James C; James EA; Sowers JR Cardiovasc Drug Rev; 2004; 22(3):215-26. PubMed ID: 15492769 [TBL] [Abstract][Full Text] [Related]
10. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus]. Kotake H; Oikawa S Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K J Atheroscler Thromb; 2013; 20(10):733-42. PubMed ID: 23892529 [No Abstract] [Full Text] [Related]
12. The use of lipid-lowering drug therapy in children and adolescents. Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879 [TBL] [Abstract][Full Text] [Related]
13. [Consensus on Cardiovascular Prevention in Childhood and Adolescence. Brief version. Recommendations]. ; Arch Argent Pediatr; 2019 Dec; 117(6):S205-S242. PubMed ID: 31758893 [TBL] [Abstract][Full Text] [Related]
14. Treatment of dyslipidaemia in childhood. Kusters DM; Vissers MN; Wiegman A; Kastelein JJ; Hutten BA Expert Opin Pharmacother; 2010 Apr; 11(5):739-53. PubMed ID: 20210683 [TBL] [Abstract][Full Text] [Related]
15. [Prevention of cardiovascular disease in adulthood should attach importance to related risk factors in childhood]. Xi B; Song Y; Ma J Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1428-1432. PubMed ID: 33076593 [TBL] [Abstract][Full Text] [Related]
16. High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Collins VR; Dowse GK; Cabealawa S; Ram P; Zimmet PZ Int J Epidemiol; 1996 Feb; 25(1):59-69. PubMed ID: 8666506 [TBL] [Abstract][Full Text] [Related]
17. Update in prevention of atherosclerotic heart disease: management of major cardiovascular risk factors. Romero-Corral A; Somers VK; Korinek J; Sierra-Johnson J; Thomas RJ; Allison TG; Lopez-Jimenez F Rev Invest Clin; 2006; 58(3):237-44. PubMed ID: 16958300 [TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis prevention and treatment in children and adolescents. Oliveira FL; Patin RV; Escrivão MA Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):513-28. PubMed ID: 20397826 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in developing countries: myths, realities, and opportunities. Pearson TA Cardiovasc Drugs Ther; 1999 Apr; 13(2):95-104. PubMed ID: 10372224 [TBL] [Abstract][Full Text] [Related]
20. Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators. Barber CE; Esdaile JM; Martin LO; Faris P; Barnabe C; Guo S; Lopatina E; Marshall DA J Rheumatol; 2016 Nov; 43(11):1965-1973. PubMed ID: 27481908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]